Foravisét at Women's HealthX 2026: Platinum Sponsor

Foravisét at Women's HealthX 2026

Platinum Sponsor | December 3–4, 2026 | Boston, Massachusetts

Foravisét is proud to be a Platinum Sponsor of Women's HealthX 2026, bringing together investors, industry leaders, clinicians, researchers, and innovators working to transform women's healthcare.

This is an opportunity to contribute to the discussions shaping the future of women's health, share our work in developing innovative non-hormonal therapeutics, and build relationships with the partners who can help bring those innovations to patients.

Our Leadership on Stage

Foravisét will play an active role in the conference program:

  • J.J. Marx, CEO, will chair the Evidence, Data & Innovation track on December 3, leading discussions on the evidence needed to translate innovation into meaningful clinical and commercial outcomes.

  • Dr. Yuval Kaufman, Chief Scientific Officer, will speak on December 4 about the iNOS/nitric oxide pathway in endometriosis and its potential relevance to a new generation of non-hormonal therapies.

Advancing a New Approach to Endometriosis

Foravisét is developing Ravisét® (FS-30), an investigational oral, non-hormonal therapy targeting inflammatory signaling associated with endometriosis.

As we advance toward our planned Phase IIa clinical study, we are challenging the longstanding reliance on hormonal suppression and exploring a fundamentally different therapeutic approach.

Let's Meet in Boston

We're coming to Women's HealthX to make connections that matter.

J.J. Marx, CEO; Mindy Gross, Chairperson of the Board; and Dr. Yuval Kaufman, CSO, will be in Boston ahead of Women's HealthX 2026.

We welcome opportunities to meet with life-sciences investors, pharmaceutical companies, and prospective strategic partners as we advance Ravisét® toward Phase IIa clinical development and prepare for our next financing round.

Our leadership will be available for meetings Monday through Wednesday, November 30–December 2, ahead of the conference.

Interested in connecting? We'd be pleased to arrange a meeting during those days.

Previous
Previous

Foravisét Named Lead Research Partner for the 2026 U.S. Women's Health Infrastructure Report